<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-07-28T08:56:56+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://diabeticinsieme.it/oms-farmaci-glp-1-lista-medicinali-essenziali/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-28T05:53:17+02:00</news:publication_date><news:title>L&#8217;Oms inserisce i farmaci GLP-1 per diabete e obesita nella lista dei medicinali essenziali</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/zimislecel-vertex-terapia-cellulare-diabete-tipo-1/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-28T05:52:54+02:00</news:publication_date><news:title>Zimislecel, la terapia cellulare di Vertex punta alle autorizzazioni globali</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/medtronic-simplera-sync-sensore-minimed-780g/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-28T05:52:34+02:00</news:publication_date><news:title>Medtronic Simplera Sync, il sensore usa-e-getta senza cerotto arriva sul MiniMed 780G</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/oltre-prediabete-stadi-diabete-tipo-2/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-28T05:51:32+02:00</news:publication_date><news:title>Oltre il prediabete, la spinta a classificare il diabete di tipo 2 in stadi</news:title></news:news></url>
</urlset>
